The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.50
Bid: 50.30
Ask: 50.40
Change: 1.45 (2.96%)
Spread: 0.10 (0.199%)
Open: 47.20
High: 50.70
Low: 47.20
Prev. Close: 49.05
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

27 Jan 2022 07:00

RNS Number : 7703Z
IP Group PLC
27 January 2022
 

 

 

 

 

IP GROUP plc (the "Company")

 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 8 October 2021 (the Buyback Programme).

Date of purchase:

26-Jan-22

Number of ordinary shares purchased:

445,556

Highest price paid per ordinary share (GBp):

 99.40

Lowest price paid per ordinary share (GBp):

 97.10

Volume weighted average price paid per ordinary share (GBp):

97.9342

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 28,696,656 of its ordinary shares in treasury and has 1,063,033,287 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,034,336,631, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Numis Securities Limited on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

26 January 2022

Number of ordinary shares purchased:

445,556

Volume weighted average price (pence):

97.9342

Individual transactions:

 

Number of sharespurchased

Transaction price(per share)

Time of transaction

Trading venue

9300

97.50

 08:19:44

LSE

92

97.50

 08:19:44

LSE

1

98.40

 09:04:45

LSE

2737

99.40

 09:52:28

LSE

266

99.40

 09:52:28

LSE

6329

99.40

 09:52:28

LSE

557

99.10

 10:00:33

LSE

9200

99.10

 10:00:33

LSE

815

98.50

 11:18:10

LSE

3000

98.50

 11:18:10

LSE

1127

98.30

 11:59:18

LSE

2636

98.40

 12:02:00

LSE

5800

98.40

 12:02:00

LSE

350

98.40

 12:02:00

LSE

9601

97.90

 12:04:00

LSE

9202

98.00

 13:36:12

LSE

10328

98.00

 14:04:18

LSE

3000

98.10

 14:33:09

LSE

9699

98.00

 14:33:47

LSE

627

98.00

 14:33:47

LSE

2749

98.20

 14:52:38

LSE

845

98.20

 14:57:25

LSE

517

98.50

 15:06:26

LSE

259

98.50

 15:06:31

LSE

183

98.50

 15:06:35

LSE

1372

98.50

 15:07:54

LSE

8418

98.30

 15:16:11

LSE

1209

98.30

 15:16:11

LSE

290

98.00

 15:29:01

LSE

693

98.00

 15:29:01

LSE

396

98.00

 15:31:06

LSE

315

98.00

 15:31:06

LSE

8924

98.00

 15:44:37

LSE

2472

97.90

 15:58:19

LSE

6701

97.90

 15:58:19

LSE

300000

97.85

 16:02:15

LSE

1085

97.90

 16:02:51

LSE

888

97.90

 16:02:51

LSE

557

98.00

 16:07:41

LSE

1425

98.00

 16:07:41

LSE

1098

98.00

 16:07:41

LSE

40

98.00

 16:07:41

LSE

450

97.80

 16:15:33

LSE

2108

97.70

 16:17:14

LSE

2065

97.70

 16:17:14

LSE

3098

97.70

 16:17:14

LSE

1900

97.70

 16:17:14

LSE

709

97.70

 16:17:14

LSE

2512

97.10

 16:27:16

LSE

3979

97.10

 16:27:18

LSE

3632

97.10

 16:27:18

LSE

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

David Gaffney

+44 (0) 7854 609998

Andrew Wilson

+44 (0) 7810 636995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGZGZMLVGGZZM
Date   Source Headline
15th Jun 20218:00 amRNSFurther re Scrip Dividend
9th Jun 202111:29 amRNSResult of AGM
9th Jun 20217:00 amRNSAGM Statement
7th Jun 20217:00 amRNSPortfolio co Iksuda completes $42m financing round
28th May 20213:36 pmRNSDirector/PDMR Shareholding
28th May 202110:00 amRNSJoint venture with China Everbright to launch fund
27th May 20217:00 amRNSPortfolio co Pulmocide completes $92m Series C
26th May 20212:44 pmRNSUpdate on AGM
20th May 202110:01 amRNSScrip Dividend Reference Price
17th May 202112:44 pmRNSAdditional fair value gain of £20m
12th May 202112:08 pmRNSHolding(s) in Company
10th May 202111:15 amRNSInvestor webinars
6th May 20216:13 pmRNSNotice of AGM, Annual Report, Scrip Dividend
6th May 20215:55 pmRNSLTIP & DBSP awards; Director/PDMR shareholding
5th May 20217:00 amRNSPortfolio company Kuur acquired by Athenex
5th May 20217:00 amRNSPortfolio company Inivata acquired by NeoGenomics
4th May 20217:00 amRNSPortfolio company Oxford Nanopore raises £195m
7th Apr 202111:27 amRNSDirector/PDMR Shareholding
31st Mar 20219:15 amRNSHolding(s) in Company
30th Mar 20217:05 amRNSOxford Nanopore announces preparing for IPO in H2
26th Mar 202112:26 pmRNSEMA positive opinion for Diurnal's Chronocort
10th Mar 20217:00 amRNSAnnual Results
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 20207:00 amRNSEnterprise Therapeutics' program acquired by Roche
23rd Sep 20201:40 pmRNSHolding(s) in Company
15th Sep 202012:07 pmRNSSecond Price Monitoring Extn
15th Sep 202012:02 pmRNSPrice Monitoring Extension
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20205:18 pmRNSForm 8.3 - Modern Water plc
5th Aug 20207:00 amRNSHalf-yearly results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.